ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1189

Baylor Rheumatology Initiative: Developing and Guiding Engagement (BRIDGE) Transition Pathway Creation and Implementation

Priyanka Moolchandani1, Cristina Saez 1, Marietta DeGuzman 1, Eyal Muscal 1, Andrea Ramirez 1, Anna Carmela Sagcal-Gironella 1, Saimun Singla 1, Amanda Brown 1, Monica Marcus 1, Martha Curry 1, Maria Pereira 1, M. Brad Nelson 1, Pooja Patel 1, W. Blaine Lapin 1, Jennifer Rammel 1, LeeGee Huang 2, Blanca Sanchez-Fournier 2, JaLeen Rogers 2, Ariel Washington 2, Anne Dykes 2, Miriah Gillispie-Taylor 1 and Tiphanie Vogel 1, 1Baylor College of Medicine, Houston, TX, 2Texas Children's Hospital, Houston, TX

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: quality improvement and pediatric rheumatology, Transition

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Measures Of Healthcare Quality Poster II: Improving Care

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with pediatric rheumatologic diseases live well into adulthood, necessitating transition from pediatric to adult medical providers. GotTransition.org details 6 core elements clinicians can implement to create effective transition: policy, registry, readiness, planning, transfer and completion.

Methods: The core elements were used to design a transition pathway. A transition policy was created, and a patient registry constructed. Provider-led education on readiness and planning were structured during clinic visits using an electronic medical record-based tool. Patient self-reported transition readiness was assessed with a patient-administered survey, the ADAPT (Adolescent Assessment of Preparation for Transition). All rheumatology providers gave input through monthly transition meetings. Provider participation was encouraged through Maintenance of Certification points.

Results: The transition policy was acknowledged and signed by 33 patients during a pilot release. 481 return patients age 14-19 years were identified by review of clinic schedules and added to the transition registry. ADAPT surveys were completed by 101 patients. Most respondents were 15-18 years of age (79%), female (70%), and Caucasian (77%); 41% were Hispanic. 28% had juvenile arthritis and 18% had lupus. Most patients had private insurance (59%) or Medicaid/Children’s Health Insurance Program (36%). Not unexpectedly, ADAPT scores increased with age, and older adolescents (18-19 years) achieved the highest averages: counseling in transition self-management (58/100) and prescription medications (93/100), and in transfer planning (33/100). All patients had scores >50/100 for medications. There was no significant difference in survey results with respect to diagnosis or age at diagnosis. Since the project began, 25 high-risk patients, average age 19.4 years, have transferred into an on-site transition clinic. Transitioned patients attended their first adult appointment an average of 3.2 months from their last pediatric appointment, and only 11% required hospitalization within the first year after transition.

Conclusion: Effective healthcare transitions are critical to the wellbeing of patients with childhood-onset rheumatologic conditions. The creation of a transition pathway in rheumatology clinic has been well received by patients and providers. We have demonstrated good scores for counseling in medications and identified a need to improve self-management and planning counseling. Future directions will include 1) formalizing the final 2 elements of the pathway for all transitioning patients, including standardizing a transition letter to the adult rheumatology provider, and 2) further assessing outcomes. Our ultimate goal is to create a sustainable and successful BRIDGE between pediatric and adult rheumatology care.


Disclosure: P. Moolchandani, None; C. Saez, None; M. DeGuzman, None; E. Muscal, None; A. Ramirez, None; A. Sagcal-Gironella, None; S. Singla, None; A. Brown, None; M. Marcus, None; M. Curry, None; M. Pereira, None; M. Nelson, None; P. Patel, None; W. Lapin, None; J. Rammel, None; L. Huang, None; B. Sanchez-Fournier, None; J. Rogers, None; A. Washington, None; A. Dykes, None; M. Gillispie-Taylor, None; T. Vogel, None.

To cite this abstract in AMA style:

Moolchandani P, Saez C, DeGuzman M, Muscal E, Ramirez A, Sagcal-Gironella A, Singla S, Brown A, Marcus M, Curry M, Pereira M, Nelson M, Patel P, Lapin W, Rammel J, Huang L, Sanchez-Fournier B, Rogers J, Washington A, Dykes A, Gillispie-Taylor M, Vogel T. Baylor Rheumatology Initiative: Developing and Guiding Engagement (BRIDGE) Transition Pathway Creation and Implementation [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/baylor-rheumatology-initiative-developing-and-guiding-engagement-bridge-transition-pathway-creation-and-implementation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/baylor-rheumatology-initiative-developing-and-guiding-engagement-bridge-transition-pathway-creation-and-implementation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology